Alopecia Areata
This week, there is interesting news for those with alopecia areata. Nektar Therapeutics has announced that it will launch a Phase 2b trial for its drug rezpegaldesleukin (REZPEG), which will be assessed in individuals suffering from severe to very severe alopecia areata (AA). Nektar Therapeutics is a biotech firm with several indications in the pipeline…
Read MoreI wanted to give everyone a quick update on one of the hottest topics in the hair growth treatment world, the Brotzu lotion. Dr. Giovanni (John) Brotzu made a presentation last weekend at an Italian Alopecia Areata Association meeting. The presentation contains a few interesting new tidbits and is completely in Italian, but is somewhat…
Read More